Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Address
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA 94080
Founded
2012
Number of Employees
32
Website
http://quincetx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)